-

Pharmacy Quality Solutions Announces Strategic Partnership with Pyrls to Transform Clinical Workflow for Pharmacists

Integration Delivers Instant Access to Critical Clinical Data for 50,000+ Clinicians Through EQUIPP Copilot

SAN FRANCISCO--(BUSINESS WIRE)--Pharmacy Quality Solutions (PQS), an Innovaccer company and leader in pharmacy-payer performance technology, today announced a strategic partnership with Pyrls, the Y Combinator-backed clinical drug information platform trusted by over 50,000 clinicians and student clinicians. This collaboration integrates Pyrls' powerful drug information hub directly into EQUIPP Copilot, creating a seamless experience that supercharges clinical insights and empowers clinicians to deliver better patient care.

The partnership addresses a critical challenge facing today's pharmacists, of accessing reliable, comprehensive drug information without disrupting their workflow. By embedding Pyrls' trusted clinical data within EQUIPP Copilot, pharmacists can now access vital drug information exactly when and where they need it, eliminating the need to toggle between systems or search multiple sources. The integration provides clear counseling points to guide patient conversations, instant drug summaries covering pharmacotherapy and pharmacology, visual pill identification, real-time drug interaction screening, and additional comprehensive clinical tools.

"We are thrilled to partner with Pyrls to fundamentally improve the clinical workflow and insights for pharmacists," said Todd Sega, Managing Director at Pharmacy Quality Solutions. "EQUIPP Copilot was designed to meet pharmacies where they are, integrate into their workflow, and provide a zero-click solution for identifying and documenting clinical services opportunities. This partnership directly contributes to this core solution, and we are excited to bring our users tools, like Pyrls, to supercharge the clinical information at their fingertips."

"Pharmacists make countless clinical decisions every day, and they deserve drug information that's instantly accessible, reliable, and easy to use," said Derek Borkowski, CEO at Pyrls. "By integrating Pyrls directly into EQUIPP Copilot, we're eliminating workflow friction and placing clinician-curated tools exactly where pharmacists need them. This collaboration empowers faster decisions, clearer counseling, and ultimately better patient care.”

The integration represents a significant advancement in pharmacy technology, combining PQS's proven workflow optimization capabilities with Pyrls' comprehensive drug information database. This partnership enables pharmacists to deliver higher-quality patient care while simultaneously identifying and documenting clinical interventions that drive both health outcomes and revenue.

About PQS by Innovaccer

PQS by Innovaccer aligns healthcare payers and pharmacies to achieve their shared goals of better patient outcomes and healthcare quality performance. As a neutral, trusted intermediary supporting the evolution of value-based care, PQS facilitates nationwide pharmacy-based care through our partners and the EQUIPP® platform. Utilizing deep clinical pharmacy knowledge and over a decade of performance management experience, we help clients develop strategies, implement quality improvement programs, and optimize the quality of healthcare for their populations served. For more information on how PQS can support you, please visit www.pharmacyquality.com.

About Pyrls

Pyrls is a web and mobile drug information platform that provides pharmacists and clinical teams with curated, evidence-based resources to support safer, more efficient patient care. More than 100,000 clinicians rely on Pyrls for concise drug summaries, pharmacotherapy guidance, and decision-support tools that fit naturally into pharmacy workflows across retail, health-system, specialty, and academic settings. For more information, please visit www.pyrls.com.

Contacts

Media Contact:
Arushi Awasthi
Innovaccer Inc.
arushi.awasthi@innovaccer.com
415-562-2139

Innovaccer Inc.


Release Versions

Contacts

Media Contact:
Arushi Awasthi
Innovaccer Inc.
arushi.awasthi@innovaccer.com
415-562-2139

More News From Innovaccer Inc.

Innovaccer Acquires CaduceusHealth to Make Revenue Cycle Autonomous

SAN FRANCISCO--(BUSINESS WIRE)--Innovaccer Inc., a leading healthcare AI company, today announced the asset acquisition of CaduceusHealth, a nationally recognized revenue cycle management services provider. The acquisition expands Innovaccer's Flow suite to full-stack revenue cycle capabilities, making Flow the first AI-native platform that unifies scheduling, patient engagement, and end-to-end revenue cycle management into a single operating layer for ambulatory care. This marks Innovaccer's f...

Nearly 80% of Health Plans Now Prefer Vendor-Built AI Over In-House, Innovaccer Survey Finds

SAN FRANCISCO--(BUSINESS WIRE)--Innovaccer Inc., a leading Healthcare AI company, today published The AI-Powered Payer: Leaders' Perspectives for 2026, a survey-based research report examining how health insurance executives are approaching AI investment, deployment, and organizational readiness heading into the next phase of healthcare autonomy. The findings draw on responses from C-suite and senior leaders across 63 major health insurers, ranging from regional health plans to national carrier...

CMS Accepts Innovaccer for the ACCESS Model, Giving Health Systems a Zero-Risk Path to Medicare's Chronic Care Revolution

SAN FRANCISCO--(BUSINESS WIRE)--Innovaccer, a leading healthcare AI company, today announced that the Centers for Medicare & Medicaid Services (CMS) has accepted its application under Story Health Partners for the Advancing Chronic Care with Effective, Scalable Solutions (ACCESS) Model, positioning the company for participation at the program's July 2026 launch. Innovaccer has been accepted across both Early Cardio-Kidney-Metabolic (eCKM) and Cardio-Kidney-Metabolic (CKM) tracks, spanning h...
Back to Newsroom